TY - JOUR
T1 - Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers
AU - the ALLFTD consortium
AU - Flagan, Taru M.
AU - Chu, Stephanie A.
AU - Häkkinen, Suvi
AU - Zhang, Liwen
AU - McFall, David
AU - Rohrer, Jonathan D.
AU - Brown, Jesse A.
AU - Lee, Alex J.
AU - Fernhoff, Kristen
AU - Pasquini, Lorenzo
AU - Rankin, Katherine P.
AU - Mandelli, Maria Luisa
AU - Gorno-Tempini, Maria Luisa
AU - Yokoyama, Jennifer S.
AU - Sturm, Virginia E.
AU - Appleby, Brian
AU - Dickerson, Bradford C.
AU - Domoto-Reilly, Kimiko
AU - Foroud, Tatiana
AU - Geschwind, Daniel H.
AU - Ghoshal, Nupur
AU - Graff-Radford, Neill R.
AU - Hsiung, Ging Yuek Robin
AU - Huang, Eric J.
AU - Huey, Edward
AU - Kantarci, Kejal
AU - Litvan, Irene
AU - Mackenzie, Ian R.
AU - Mendez, Mario F.
AU - Onyike, Chiadi U.
AU - Petrucelli, Leonard
AU - Ramos, Eliana Marisa
AU - Roberson, Erik D.
AU - Rojas, Julio C.
AU - Tartaglia, Maria Carmela
AU - Toga, Arthur W.
AU - Weintraub, Sandra
AU - Forsberg, Leah K.
AU - Heuer, Hilary W.
AU - Boeve, Brad F.
AU - Boxer, Adam L.
AU - Rosen, Howard J.
AU - Miller, Bruce L.
AU - Moreno, Fermin
AU - Seeley, William W.
AU - Lee, Suzee E.
N1 - Publisher Copyright:
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
PY - 2025/12
Y1 - 2025/12
N2 - Objective: Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN-related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed that asymptomatic GRN variant carriers exhibit thalamocortical hyperconnectivity that increases with age, presumably as they are approaching symptom onset. Whether hyperconnectivity arises concomitantly with markers of neurodegeneration remains unclear. Methods: Utilizing T1 and task-free functional magnetic resonance imaging from 49 asymptomatic and 26 symptomatic GRN variant carriers, we determined the relationships between functional connectivity, as measured by voxelwise whole-brain degree, and GRN-relevant markers of disease progression, including plasma neurofilament light chain concentrations, cerebrospinal fluid complement C1q and C3b protein levels, obsessive-compulsive disorder symptom severity, and gray matter volume. Results: Neurofilament light chain concentrations were associated with frontotemporoparietal and thalamic hyperconnectivity in asymptomatic GRN variant carriers and extensive regions of atrophy in symptomatic carriers. Complement levels were associated with regions of hyperconnectivity, but not gray matter volume, in symptomatic carriers. Obsessive-compulsive disorder symptom severity was associated with hypoconnectivity across all GRN carriers. Asymptomatic carriers with thalamic hyperconnectivity tended to have lower gray matter volume in the bilateral insula and left lateral parietal cortex, early regions of atrophy in GRN-frontotemporal dementia. Interpretation: In asymptomatic carriers, the co-occurrence of hyperconnectivity, high neurofilament light chain, and low gray matter volume suggests that functional hyperconnectivity may portend the onset of clinical decline. These findings point toward hyperconnectivity as an indicator of approaching symptomatic onset.
AB - Objective: Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN-related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed that asymptomatic GRN variant carriers exhibit thalamocortical hyperconnectivity that increases with age, presumably as they are approaching symptom onset. Whether hyperconnectivity arises concomitantly with markers of neurodegeneration remains unclear. Methods: Utilizing T1 and task-free functional magnetic resonance imaging from 49 asymptomatic and 26 symptomatic GRN variant carriers, we determined the relationships between functional connectivity, as measured by voxelwise whole-brain degree, and GRN-relevant markers of disease progression, including plasma neurofilament light chain concentrations, cerebrospinal fluid complement C1q and C3b protein levels, obsessive-compulsive disorder symptom severity, and gray matter volume. Results: Neurofilament light chain concentrations were associated with frontotemporoparietal and thalamic hyperconnectivity in asymptomatic GRN variant carriers and extensive regions of atrophy in symptomatic carriers. Complement levels were associated with regions of hyperconnectivity, but not gray matter volume, in symptomatic carriers. Obsessive-compulsive disorder symptom severity was associated with hypoconnectivity across all GRN carriers. Asymptomatic carriers with thalamic hyperconnectivity tended to have lower gray matter volume in the bilateral insula and left lateral parietal cortex, early regions of atrophy in GRN-frontotemporal dementia. Interpretation: In asymptomatic carriers, the co-occurrence of hyperconnectivity, high neurofilament light chain, and low gray matter volume suggests that functional hyperconnectivity may portend the onset of clinical decline. These findings point toward hyperconnectivity as an indicator of approaching symptomatic onset.
KW - frontotemporal dementia with GRN pathogenic variants
KW - functional connectivity
KW - markers of disease progression
UR - https://www.scopus.com/pages/publications/105018093318
U2 - 10.1002/acn3.70170
DO - 10.1002/acn3.70170
M3 - Article
C2 - 40958169
AN - SCOPUS:105018093318
SN - 2328-9503
VL - 12
SP - 2575
EP - 2588
JO - Annals of Clinical and Translational Neurology
JF - Annals of Clinical and Translational Neurology
IS - 12
ER -